Osteogenesis and bone-marrow-derived cells

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 3, 2001, Pages 677-690

  Long, Michael W ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MSRB I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 0034889271     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0431     Document Type: Conference Paper

References (125)

1. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase
2. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
3. Advances in the osteoblast lineage
4. Characterization of stromal progenitor cells enriched by flow cytometry
5. Multilineage potential of adult human mesenchymal stem cells
6. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues
7. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats
8. Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges
9. Characterization of cells with high alkaline phosphatase activity derived from human bone preliminary assessment of their osteogenicity
10. Colony forming cell-fibroblast development in extracellular matrix-induced bone and bone marrow formation in rat
11. The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors
12. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells
13. A role for osteocalcin in osteoclast differentiation
14. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro
15. Tissue-engineered bone regeneration
16. Bone marrow stromal cells: Characterization and clinical application
17. Bone stem cells
18. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues
19. Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo
20. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers
21. Bone formation in organ cultures of bone marrow
22. Development of osteogenic tissue in diffusion chambers from early precursor cells in bone marrow of adult rats
23. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo
24. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F
25. Assessment of an in vivo diffusion chamber method as a quantitative assay for osteogenesis
26. Osteogenesis in transplants of bone marrow cells
27. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F
28. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures
29. The influences of non-osteogenic hematopoietic cells on bone formation by bone marrow stromal cell populations
30. Osteogenic progenitor cells in rat bone marrow stromal populations exhibit self-renewal in culture
31. Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell-cell interactions in osteoblast differentiation
32. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro
33. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemical studies at the single cell level
34. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
35. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation
36. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow
37. Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone
38. Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro
39. Expression of bone-related proteins in the human hematopoietic microenvironment
40. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors
41. Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody
42. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation
43. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation
44. Osteoblastic differentiation and mRNA analysis of STRO-1-positive human bone marrow stromal cells using primary in vitro culture and poly (A) PCR
45. Age-related alterations of bone cell phenotype in populations of purified human bone precursor cells
46. Bone marrow accessory cells regulate human bone precursor cell development
47. Age-associated changes in the stimulatory effect of transforming growth factor beta on human osteogenic colony formation
48. Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria
49. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts
50. The nature and significance of osteopontin
51. Immunohistochemical localization of osteonectin in developing human and calf bone using monoclonal antibodies
52. Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines
53. Relationships between cellular condensation, preosteoblast formation and epithelial-mesenchymal interactions in initiation of osteogenesis
54. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
55. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential
56. PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis
57. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts
58. Cell substratum modulates responses of preosteoblasts to retinoic acid
59. Marrow stroma-derived osteogenic clonal cell lines: Putative stages in osteoblastic differentiation
60. Integration of FGF and TWIST in calvarial bone and suture development
61. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts
62. Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells
63. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells
64. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin
65. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies
66. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies
67. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1
68. Three-dimensional cellular development is essential for the ex vivo formation of human bone
69. Autocrine growth factors and cancer
70. Human bone morphogenic protein (hBMP)
71. Novel regulators of bone formation: Molecular clones and activities
72. Bone matrix-induced local bone induction
73. Bone cell differentiation and growth factors
74. Solubilization and purification of bone morphogenetic protein (BMP) from dunn osteosarcoma
75. Characterization of mitogenic activities extracted from bovine bone matrix
76. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats
77. Fibroblast growth factor enhances type β1 transforming growth factor gene expression in osteoblast-like cells
78. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats
79. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors
80. The TGF-beta family of growth and differentiation factors
81. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
82. Insulin-like growth factor binding proteins in bone cell regulation
83. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63
84. Role of transforming growth factor-beta in bone remodeling
85. Response of bipotential human marrow stromal cells to insulin-like growth factors: Effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes
86. Hydroxyapatite coated with insulin-like growth factor 1 (IGF1) stimulates human osteoblast activity in vitro
87. Calcitonin increases the concentration of insulin-like growth factors in serum-free cultures of human osteoblast-line cells
88. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: Attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin
89. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation
90. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
91. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats
92. The role of insulin-like growth factors and binding proteins in bone cell biology
93. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae
94. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent
95. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
96. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo
97. Osteonectin in matrix remodeling. A plasminogen- osteonectin-collagen complex
98. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
99. In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization
100. Increased bone formation in osteocalcin-deficient mice
101. Characterization of a gamma-carboxyglutamic acid-containing protein from bone
102. Osteonectin, a bone-specific protein linking mineral to collagen
103. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose
104. Effect of growth factors on bone cell replication and differentiation
105. Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation
106. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules
107. The osteoblast: A sophisticated fibroblast under central surveillance
108. The developmental control of osteoblast-specific gene expression: Role of specific transcription factors and the extracellular matrix environment
109. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
110. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
111. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage
112. Production and action of transforming growth factor-beta in human osteoblast cultures: Dependence on cell differentiation and modulation by calcitriol
113. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression
114. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation
115. Regulation of vascular integrins
116. The mouse bagpipe gene controls development of axial skeleton, skull, and spleen
117. Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: A putative Rho/Rac guanine nucleotide exchange factor
118. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome)
119. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation
120. Divide, accumulate, differentiate: Cell condensation in skeletal development revisited
121. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-β1
122. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells
123. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells
124. N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: Stimulation by poly-L-lysine
125. Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone